Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Angiodynamics (ANGO) Total Debt (2016 - 2025)

Historic Total Debt for Angiodynamics (ANGO) over the last 17 years, with Q1 2025 value amounting to $5.0 million.

  • Angiodynamics' Total Debt fell 4736.84% to $5.0 million in Q1 2025 from the same period last year, while for Feb 2025 it was $5.0 million, marking a year-over-year decrease of 4736.84%. This contributed to the annual value of $4.7 million for FY2024, which is 9267.87% down from last year.
  • Per Angiodynamics' latest filing, its Total Debt stood at $5.0 million for Q1 2025, which was down 4736.84% from $5.0 million recorded in Q4 2024.
  • Angiodynamics' 5-year Total Debt high stood at $64.6 million for Q2 2023, and its period low was $4.7 million during Q2 2024.
  • Its 5-year average for Total Debt is $26.1 million, with a median of $25.0 million in 2021.
  • Per our database at Business Quant, Angiodynamics' Total Debt skyrocketed by 13873.6% in 2023 and then crashed by 9267.87% in 2024.
  • Over the past 5 years, Angiodynamics' Total Debt (Quarter) stood at $25.0 million in 2021, then soared by 138.22% to $59.6 million in 2022, then crashed by 84.24% to $9.4 million in 2023, then crashed by 47.16% to $5.0 million in 2024, then rose by 0.81% to $5.0 million in 2025.
  • Its Total Debt stands at $5.0 million for Q1 2025, versus $5.0 million for Q4 2024 and $4.8 million for Q3 2024.